Skip to main content
. 2020 Oct 19;8(2):582–591. doi: 10.1002/nop2.663

TABLE 1.

Demographic characteristics and medical history of the participants by groups

Parameter Healthy group n (%) Patient group I n (%) Patient group II n (%) p‐value
Mean Age, year (SD) 63.15 (11.34) 62.14 (10.72) 64.75 (10.45) .206 a
Gender
Female 58 (48.7) 50 (45) 51 (47.7) .848 b
Male 61 (51.3) 61 (55) 56 (52.3)
ACS
Myocardial infarction 59 (53.2) 45 (42.1)
Unstable angina 52 (46.8) 62 (57.9)
Medical history
Hypertension 83 (69.7) 73 (65.8) 84 (78.5) .105 b
Diabetes 31 (26.1) 29 (26.1) 33 (30.8) .662 b
Hyperlipidemia 40 (33.6) 37 (33.3) 41 (38.3) .686 b
Low back pain 18 (15.1) 11 (9.9) 14 (13.1) .492 b
Rheumatoid arthritis 27 (22.7) 20 (18) 18 (16.8) .492 b
Thyroid condition 9 (7.6) 7 (6.3) 6 (5.6) .833 b
IBS, Peptic Ulcer, Oesophageal Reflux 4 (3.4) 3 (2.7) 3 (2.8) .951 b
COPD, Asthma 3 (2.5) 3 (2.7) 6 (5.6) .408 b
Sinusitis, migraine 6 (5.6) 5 (4.5) 3 (2.5) .480 b
BPH 4 (6.6) 3 (4.9) 6 (10.7) .478 b
Other 12 (10.1) 11 (9.9) 13 (12.1) .837 b
a

Using ANOVA.

b

Using chi‐square tests; other: depression, anaemia, cerebrovascular accident, epilepsy, cholecystitis, fatty liver disease and a cold. Patient group I: participants with ACS incidence and without a history of ischaemic heart disease, patient group II: participants with ACS incidence and with a history of ischaemic heart disease; healthy group: participants without ACS incidence; ACS, acute coronary syndrome; IBS, irritable bowel syndrome; COPD, chronic obstructive pulmonary disease; BPH, benign prostatic hyperplasia; SD, standard deviation.